Cadence Bank NA’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-77,302
| Closed | -$4.05M | – | 152 |
|
|
2022
Q2 | $4.05M | Sell |
77,302
-3,626
| -4% | -$185K | 1.31% | 16 |
|
|
2022
Q1 | $4.19M | Sell |
80,928
-311
| -0.4% | -$16.1K | 1.17% | 19 |
|
|
2021
Q4 | $4.8M | Sell |
81,239
-849
| -1% | -$42.1K | 1.31% | 16 |
|
|
2021
Q3 | $3.53M | Buy |
82,088
+2,134
| +3% | +$94.5K | 1.05% | 25 |
|
|
2021
Q2 | $3.13M | Sell |
79,954
-405
| -0.5% | -$15.7K | 0.94% | 33 |
|
|
2021
Q1 | $2.91M | Buy |
80,359
+3,487
| +5% | +$124K | 0.92% | 33 |
|
|
2020
Q4 | $2.83M | Sell |
76,872
-2,472
| -3% | -$90.7K | 1% | 31 |
|
|
2020
Q3 | $2.76M | Buy |
79,344
+1,424
| +2% | +$49.9K | 1.07% | 29 |
|
|
2020
Q2 | $2.42M | Buy |
77,920
+2,220
| +3% | +$75.4K | 1.02% | 28 |
|
|
2020
Q1 | $2.34M | Sell |
75,700
-21,910
| -22% | -$747K | 1.2% | 21 |
|
|
2019
Q4 | $3.63M | Buy |
97,610
+619
| +0.6% | +$22K | 1.34% | 17 |
|
|
2019
Q3 | $3.31M | Buy |
96,991
+2,385
| +3% | +$86.7K | 1.3% | 17 |
|
|
2019
Q2 | $3.89M | Sell |
94,606
-5,076
| -5% | -$202K | 1.52% | 12 |
|
|
2019
Q1 | $4.02M | Sell |
99,682
-407
| -0.4% | -$16.3K | 1.57% | 12 |
|
|
2018
Q4 | $4.14M | Buy |
100,089
+3,823
| +4% | +$159K | 1.86% | 10 |
|
|
2018
Q3 | $4.03M | Sell |
96,266
-173
| -0.2% | -$6.66K | 1.53% | 11 |
|
|
2018
Q2 | $3.32M | Sell |
96,439
-6,311
| -6% | -$216K | 1.36% | 13 |
|
|
2018
Q1 | $3.46M | Sell |
102,750
-4,333
| -4% | -$149K | 1.38% | 13 |
|
|
2017
Q4 | $3.68M | Buy |
107,083
+3,109
| +3% | +$106K | 1.35% | 12 |
|
|
2017
Q3 | $3.52M | Sell |
103,974
-1,386
| -1% | -$44.5K | 1.33% | 12 |
|
|
2017
Q2 | $3.36M | Buy |
105,360
+1,505
| +1% | +$47.5K | 1.53% | 13 |
|
|
2017
Q1 | $3.37M | Buy |
103,855
+4,986
| +5% | +$157K | 1.55% | 14 |
|
|
2016
Q4 | $3.05M | Buy |
98,869
+2,426
| +3% | +$74.1K | 1.43% | 14 |
|
|
2016
Q3 | $3.1M | Buy |
96,443
+2,643
| +3% | +$88.4K | 1.4% | 20 |
|
|
2016
Q2 | $3.13M | Sell |
93,800
-4,440
| -5% | -$142K | 1.54% | 13 |
|
|
2016
Q1 | $2.76M | Sell |
98,240
-4,549
| -4% | -$130K | 1.43% | 17 |
|
|
2015
Q4 | $3.15M | Buy |
102,789
+3,844
| +4% | +$121K | 1.68% | 14 |
|
|
2015
Q3 | $2.95M | Buy |
98,945
+38,897
| +65% | +$1.25M | 1.7% | 12 |
|
|
2015
Q2 | $1.91M | Buy |
60,048
+36
| +0.1% | +$1.17K | 1.24% | 17 |
|
|
2015
Q1 | $1.98M | Buy |
60,012
+4,737
| +9% | +$151K | 1.1% | 15 |
|
|
2014
Q4 | $1.63M | Sell |
55,275
-4,014
| -7% | -$115K | 0.87% | 20 |
|
|
2014
Q3 | $1.66M | Sell |
59,289
-2,764
| -4% | -$77.6K | 0.9% | 21 |
|
|
2014
Q2 | $1.75M | Buy |
62,053
+1,371
| +2% | +$39.1K | 0.94% | 18 |
|
|
2014
Q1 | $1.85M | Sell |
60,682
-9,298
| -13% | -$277K | 1.1% | 15 |
|
|
2013
Q4 | $2.03M | Buy |
69,980
+354
| +0.5% | +$10.3K | 1.1% | 15 |
|
|
2013
Q3 | $1.9M | Sell |
69,626
-1,681
| -2% | -$45.7K | 1.14% | 14 |
|
|
2013
Q2 | $1.9M | Buy |
+71,307
| New | +$1.97M | 1.04% | 17 |
|
Other funds holding PFE
Cadence Bank NA's PFE Position: Q3 2022 in Review
Cadence Bank NA sold out of Pfizer (PFE) in Q3 2022, closing a stake of 77,302 shares — an estimated $4.05M sold.
Cadence Bank NA first reported a position in PFE in Q2 2013 and held it in 37 quarters. The position peaked at $4.8M in Q4 2021. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.
- Cadence Bank NA reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
- Cadence Bank NA sold 77,302 Pfizer shares in Q3 2022, an estimated $4.05M.
- Cadence Bank NA first reported a position in Pfizer in Q2 2013 and held it in 37 quarters.
- Cadence Bank NA's Pfizer position peaked at $4.8M in Q4 2021.
- 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.
Based on Cadence Bank NA's 13F filing for Q3 2022, filed 27 Oct 2022.